Cellmid Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellmid Limited with three other
companies in this sector in AUSTRALIA :
Paradigm Biopharmaceuticals Ltd
sales of 4.70 million Australian Dollars [US$3.64 million]
Starpharma Holdings Limited
(7.12 million Australian Dollars [US$5.51 million]
of which 100%
was Discovery, development & commercial of D), and
Medlab Clinical Ltd
(5.37 million Australian Dollars [US$4.16 million]
of which 67%
was Pharmaceutical Research).
Cellmid Limited reported sales of A$7.48 million (US$5.80 million)
June of 2020.
a very small
increase of 0.2%
versus 2019, when the company's sales were A$7.47 million.
Sales at Cellmid Limited have increased during each of the previous five years
(and since 2015, sales have increased a total of 280%).